Research Paper Volume 15, Issue 19 pp 10746—10766
A pan-cancer analysis of the role of HOXD1, HOXD3, and HOXD4 and validation in renal cell carcinoma
Figure 7. HOXD3 inhibits KIRC progression in vivo. (A) HOXD3 expression in LV-OV-HOXD3 and LV-OV-HOXD3-Ctrl cells was identified by qRT-PCR. (B) On day 28, the tumor was tested by bioluminescence imaging. (C) Tumor weight. (D) Tumor growth curves. (E, F) HOXD3 expression in tumor xenografts was confirmed by qRT-PCR and western blotting (**p < 0.01).